Europe accuses drug makers of padding healthcare costs

New York Times, December 1, 2008

The European Union has accused drug companies of adding billions of dollars to healthcare costs by delaying or blocking the sale of less expensive generic medicines. Patients and healthcare systems in Europe would have saved at least 3 billion euros, or $3.8 billion, from 2000 to 2007—or shaved 5% off the medical bills—if companies had let generics into the market sooner, said Neelie Kroes, the European competition commissioner.


MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2015 a division of BLR All rights reserved.